The development of electrophoresis has permitted the study of body-fluid protein changes in health and disease. Most reports on electrophoretic analysis in hepatic diseases are based upon findings in serum rather than plasma. The chief reasons for the preference of serum over plasma are: (a) it avoids the use of anticoagulants such as heparin which may affect the electrophoretic pattern (1) , (b) it permits comparison of electrophoretic data with the usual flocculation tests performed on serum, (c) it avoids the difficulty of differentiating protein complexes having a mobility similar to that of fibrinogen and forming with it a single peak which is incapable of resolution into its constituent components (2) .
In a recent study of electrophoretic plasma protein partition of patients with hepatic diseases, especially those with cirrhosis, unexpected fibrinogen and gamma globulin values were noted. The "fibrinogen" peaks were markedly elevated and the gamma globulin elevations were not as high as expected from previous serum electrophoresis and chemical partition. To blood proteins. This study was planned to give general information on possible differences in the electrophoretic pattern of serum and plasma of normal persons as well as patients with hepatic and other diseases.
MATERIALS AND METHODS

Clinical Material
The subjects for the study came from three groups: (1) a group with liver disease made up of 23 cirrhotics (22 of the Laennec type and one post-necrotic), six cases of infectious and six of toxic hepatitis (two arsenic, one post-pneumonic and three of unknown etiology whose clinical and biopsy pictures resembled toxic hepatitis of known toxic etiology) and three cases of extrahepatic obstruction (two pancreatic neoplasms and one case of common duct lithiasis); (2) a miscellaneous group of 15 cases of rheumatoid arthritis, two of gastric ulcer and one of multiple myeloma; and (3) a normal group composed of 10 doctors and technicians working in the laboratory.
Hepatic tests were performed upon all subjects. In addition all but five of the patients with hepatic disease had needle or surgical biopsies performed for confirmation of the diagnoses. All diagnoses were made by clinical, laboratory or surgical means.
Method
Approximately 50 ml. of blood were drawn from every subject in the fasting state. Ten ml. were placed in a dry clean test tube and allowed to clot, after which the serum was separated by centrifugation. Another (4) , to obtain the percentage of the total area assigned to each protein fraction. Mobility measurements were made from the boundary anomaly of the pattern. Only descending patterns were used. The relative concentrations, calculated from the proportions of the component peaks of the patterns, were converted to absolute concentrations expressed in grams/ 100 ml. of the total serum protein which had been determined chemically. Total serum proteins were determined by the Weichselbaum modification of the biuret reaction (5) . The nitrogen to protein conversion factor used was 6.25. In 27 instances fibrinogen was determined chemically by standard laboratory methods of calcium salt precipitation and nitrogen determination (6) .
Total plasma proteins were not determined chemically. The normal values for serum are practically identical with those of plasma despite a fibrinogen content of 200-400 mg./100 ml. in the latter (7, 8) . The addition of an anticoagulant increases the plasma salt concentration and causes diffusion of water out of the erythrocytes. The presence of fibrinogen in plasma is thus nullified by the increased dilution of the plasma (9) . When comparing absolute plasma and serum findings it is desirable to reduce this source of error. A formula was utilized to calculate the total plasma proteins from the absolute serum protein values and the relative percentages of the serum and plasma electrophoretic components. The formula and its derivation are as follows: N = total plasma protein in grams/100 ml. S = total serum protein in grams/100 ml. X = plasma fibrinogen content in grams/100 ml. ences between alpha globulins in serum and plasma were not significant. Figure 2b reveals that the spread on either side of the theoretical line of perfect correlation is greater than that of any of the other components. This was particularly true of the alpha2 fraction.
Beta globulins (Table I) were increased in liver diseases as others have found (13) (14) (15) . The relative percentage values in serum and plasma vary significantly but after they are converted to absolute values the variation loses its significance and does not exceed the limits of error of the method. Figure 2c reveals a good correlation between absolute values of beta globulin in serum and plasma.
The characteristically elevated gamma globulin in liver disease and rheumatoid arthritis is well illustrated in Tables I and III . This increase was most marked in cirrhosis, less so in hepatitis and least in obstructive jaundice and miscellaneous group. These findings are in agreement with those of previous authors (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (Tables I and III) . Figure 1 reveals the cause of this significant discrepancy between serum and plasma gamma globulin values. The serum gamma globulin is composed of two fractions of different mobilities, a fraction labelled gamma2 and a fraction with a greater mobility labelled gamma1. This latter fraction has a mobility similar to fibrinogen and is therefore buried in the "fibrinogen" peak in the plasma pattern (Figure 1) . Thus the apparent plasma gamma is the equivalent of the gamma2 serum fraction (Tables I, III, Figures 1, 3) . If the serum gamma1 is determined in grams/100 ml. and this absolute value is then added to the absolute plasma gamma globulin value, the resultant corrected plasma gamma globulin value approaches the serum value. The difference between the serum gamma globulin and the corrected plasma gamma globulin then falls within the inherent error of the electrophoretic method (Tables I, III, Figures 3, 4) . In cirrhosis this gamma1 fraction is increased almost threefold from an average value of 2.5%o in the normal group to 7.1%o. There is a moderate increase in gamma1 in the three obstructive jaundice cases. Only a slight increase in this component was present in the hepatitis cases and normal values were obtained in the miscellaneous group despite somewhat increased total gamma globulins in this latter group. After correction, the plasma total gamma globulin values were still lower than the serum values although the differences were much less than before correction. Prior to correction of (Tables I, IV , Figure 5 ).
There is a good correlation between the albuminglobulin ratio as determined electrophoretically in the serum and plasma especially after the plasma total globulin has been corrected by the addition of gamma, globulin (Table I, Figure 2d ).
-In comparing the serum-plasma electrophoretic patterns, an unexpected finding was the fact that the greatest variations in the protein components were in the normals and this was true of all components. DISCUSSION Electrophoretic analysis has been employed widely in recent years to study blood protein changes in liver disease (10-15, 19, 21) . Usually this has been performed upon serum for the reasons previously mentioned. Dole (9) z lution one would expect the fractions of total proteins to be about 4-5%o greater in serum than in plasma with its fibrinogen (9) . For a proper evaluation of any possible differences between serum and plasma electrophoretic values, the comparison should be made between absolute values determined from total serum and plasma proteins corrected for anticoagulant dilution of the plasma. Heparin alters the electrophoretic pattern (1). Theoretically, potassium oxalate might possibly cause changes due to chemical denaturation of the protein. However, in previous studies (22) we found no appreciable changes using standard amounts of potassium oxalate as an anticoagulant.
The albumin changes in liver disease and rheumatoid arthritis (Table I) were similar to those reported by others (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) .
Reports in the literature differ as to the fate of alpha globulins in liver disease, some workers reporting irregular increases (13, 14) while others found no change (15, 21) . Gutman (23) believes that there is an association between increased alpha globulin and decreased gamma globulin values. In this study the alpha globulins showed a slight increase in all the pathologic cases, the greatest increase being in obstructive jaundice. The elevated lipids on our cases of obstructive jaundice Lipids frequently may be associated with alpha as well as beta globulins (23 (Figure 2c ). Dole (9) , in comparing the serum and plasma of a normal individual, similarly found the beta serum value elevated and believed this to be due to overlapping of the beta globulin and "fibrinogen" peaks. However, he did not compare absolute values. When this was done in our cases it tended to nullify the serum and plasma differences. The serum gamma globulin findings in the disease groups are in agreement with those recorded by previous authors (10-19, 21, 24) . The significant difference between the serum-plasma gamma globulin values (Tables I and III) , particularly in cirrhosis, is due to burial of the gamma1 fractions in the "fibrinogen" peak of the plasma pattern. The greater the gamma1 fraction the greater will be the serum-plasma difference in total gamma values. Electrophoresis, particularly in the pathologic cases, yields plasma gamma globulin values 15-20%o lower than serum values. It is important, therefore, to determine whether gamma1 globulin is increased in other diseases, lest misleading gamma globulin values be secured in plasma determinations in these diseases. The true picture of gamma globulin changes is found in serum determinations. The nature of gamma, globulin and the possible significance of its elevation in liver disease are discussed elsewhere (25) .
An analysis of the reported observations on the plasma fibrinogen content in liver disease reveals a diversity of opinion (8, 11, 15, 21) . The liver is probably the prime site of fibrinogen formation (26) , and diminution of this protein has been reported in acute hepatic insufficiency such as in the damage experimentally produced by chloroform and other toxins (27) . Diminished fibrinogen may also be found in humans in the severe hepatic insufficiency of acute yellow atrophy (8) . Elevated fibrinogen values have been reported in cirrhosis (11, 21) . Whitman and his co-workers (11) consider the possibility that the elevated "fibrinogen" peak in cirrhosis is due to an increase in gamma globulin as well as to an actual fibrinogen increase. Our data show this to be correct. The markedly elevated "fibrinogen" peaks often found in the cirrhotic electrophoretic pattern occur because the gamma1 component has a similar mobility to that of fibrinogen and is concealed in the "fibrinogen" peak. Similarly, Zeldis and Alling (28) had noted spurious elevations in fibrinogen values in plasma from dogs and had attributed this to increments from adjacent components. Even after correction of the fibrinogen values by subtracting the amount contributed by the gamma1 complex to the "fibrinogen" peak, the electrophoretic values for that component were still elevated above those determined chemically in the cirrhotic patients (Tables I, IV, Figure 5 ). It is fully realized that the electrophoretic pattern, particularly in cirrhosis, may vary depending upon the stage and course of the disease. Our cases of cirrhosis varied from those in the inactive stage to those with marked liver damage. We were primarily interested not in the type of pattern in the different liver diseases nor in the changes taking place during the course of the dis--ease, but in the comparison of the patterns in the serum and plasma determinations. Stage and course of disease had no effect upon these serumplasma differences. In fact, the only significant differences were those in the gamma globulin and these did not depend upon the -stage of disease but the type of disease. The gamma1 globulin relation to hepatic damage as measured by the cephalin flocculation, thymol turbidity and zinc sulphate turbidity tests is shown in Figure 4 of the following article (25) . SUMMARY 1. Paired serum and plasma samples of 66 persons with various hepatic or miscellaneous diseases and normal subjects were analyzed electrophoretically. The liver disease group included cases of cirrhosis, infectious and toxic hepatitis, and obstructive jaundice. The miscellaneous disease group was comprised of patients with rheumatoid arthritis, peptic ulcer, and multiple myeloma.
2. Serum protein changes in the various disease groups were similar to those previously reported by other authors.
3. Fibrinogen values were markedly elevated particularly in the cirrhotic group. This was due to the inclusion of a gamma1 globulin fraction in the "fibrinogen" peak. This was also responsible for the serum gamma globulin being significantly greater than the plasma gamma globulin. The addition of gamma1, as determined in the serum, to the total plasma gamma globulin yielded total gamma globulin values essentially similar to those of the serum. At the same time subtraction of gamma1 from the elevated fibrinogen values, as revealed by the plasma patterns, reduced these values approximately by 35-45%. After this correction, there was still a significant difference between electrophoretic and chemically determined fibrinogen, indicating an actual increase of this component in cirrhotic liver disease. The gamma1 burial in the "fibrinogen" peak was also responsible for the depressed values of total globulin and albumin/globulin ratio in plasma determinations. These likewise could be corrected for by addition of gamma1 to the plasma globulin.
4. Aside from the significant serum-plasma difference in gamma globulin, the other protein components were essentially similar in serum and plasma, particularly when expressed as grams/100 ml. The beta globulin content in relative percentage was somewhat more elevated in serum than plasma. After conversion to absolute values however, this difference was not significant. 5 . The routine use of plasma electrophoresis for the study of protein alterations in hepatic dis-eases is not recommended. It is impossible to resolve and separate completely the components of the "fibrinogen" peak. Inaccurate gamma globulin and fibrinogen values result.
